— What’s your move? Read on.
- Which lung should be protected during intubation?
- When is bronchoscopy more urgent than CT?
When to Think of It
Sick or Not Sick
The First Fifteen Minutes
- Call anesthesia/critical care, interventional pulmonology, and interventional radiology; place the patient upright and bleeding side down if known, because this protects the contralateral lung.
- Apply high-flow oxygen; if awake and protecting the airway, use a nonrebreather at 15 L/min. Avoid routine noninvasive ventilation when blood burden is high because it can delay definitive airway control and impair secretion clearance.
- If hypoxemia or airway protection is failing → prepare RSI with etomidate 0.3 mg/kg IV and rocuronium 1.2 mg/kg IV, because induction and paralysis facilitate controlled airway placement; doses may vary with shock and local protocol.
- After intubation, use a large single-lumen endotracheal tube, ideally ≥8.0 mm, because it permits therapeutic bronchoscopy. A double-lumen tube is generally harder to place and more prone to obstruction by clot.
- If the bleeding side is known and oxygenation remains inadequate → place a bronchial blocker through the endotracheal tube under bronchoscopic guidance, because it isolates the hemorrhagic lung.
- Ongoing airway bleeding in an awake or intubated adult → nebulized tranexamic acid 500 mg in 5 mL nebulized over 10–15 minutes, because antifibrinolysis may reduce local bleeding; evidence and dosing vary, so confirm institutional protocol.
- Obtain two large-bore IVs, type and crossmatch, CBC, PT/INR, fibrinogen, CMP, ABG/VBG, lactate, and platelet count; activate a massive transfusion protocol for shock or rapidly escalating blood loss.
- If hemorrhagic shock → transfuse packed RBCs 1 unit IV, with plasma and platelets according to local massive-transfusion protocol, because oxygen delivery and coagulation must be restored; exact ratios vary by institution.
- If life-threatening warfarin-associated bleeding → 4-factor PCC 25–50 units/kg IV based on INR, maximum 5,000 units, plus vitamin K 10 mg IV slowly, because PCC rapidly replaces factors while vitamin K sustains reversal; verify product-specific dosing.
- If severe thrombocytopenia with active bleeding → platelets 1 apheresis unit IV, because primary hemostasis may be inadequate; target thresholds depend on bleeding and procedure.
- Avoid blind suctioning or blind bronchial instrumentation when possible; clot can be displaced into the only ventilated lung.
Definitive Care & Disposition
How This One Kills
- Hematemesis — nausea, epigastric symptoms, or coffee-ground material; confusing it with hemoptysis delays airway and bronchial intervention.
- Upper-airway bleeding — blood seen in the oropharynx without pulmonary parenchymal findings; bronchoscopy and embolization may be misdirected.
- Diffuse alveolar hemorrhage — anemia, hypoxemia, bilateral infiltrates, and often modest rather than dramatic external bleeding; treating only a focal bronchial artery source misses vasculitis or pulmonary–renal disease.
- Pulmonary embolism — pleuritic pain and hypoxemia with usually scant hemoptysis; anticoagulation can worsen an unrecognized active airway hemorrhage.
The Second-Day Story
Study Directive
- Rehearse a 60-second massive-hemoptysis team script: position, suction, oxygen, airway, bronchoscopy, embolization.
- Draw the airway-isolation plan, including bronchial blocker placement, from memory.
- Review local massive-transfusion and anticoagulant-reversal protocols.
- Practice distinguishing hemoptysis, hematemesis, and upper-airway bleeding using five brief cases.
- Know the indications for CT angiography, bronchoscopy, embolization, and surgery.
Recent Literature
-
Review or guideline High risk and low incidence diseases: Massive hemoptysis
Provides an emergency-focused framework for rapid airway control, bleeding-side-down positioning, localization, and early coordination for bronchoscopy and bronchial artery embolization in life-threatening hemoptysis.